NEW YORK--(BUSINESS WIRE)--The Conference Forum announced their new event on Executing Global Clinical Trial Operations in Washington, D.C. on September 28-29. The purpose of the program is to ultimately help the industry reduce clinical development time and features industry speakers from Purdue, Astellas, Pfizer, Eli Lilly, Sucampo, Otsuka Pharmaceutical Development & Commercialization, BBK, Combinatorx, RPS, Penn Center for Bioethics, Cephalon, PhRMA, AON, AHRQ and more. The conference features fresh data on country comparisons with regards to costs, study start ups and barriers to equip the industry in making better strategic decisions in choosing what country for what trial at what phase.
